RE: MrMagoo3111 Mar 2019 09:48
and again this is AIM, not the FTSE100 where you have established companies, making a profit, and where there is often a direct correlation between performance and SP.
Not so on AIM, I am afraid: this is more the wild west. With start ups, or at least very young companies, who need easy acces to equity to build their business. So, it’s a case of choosing the right AIm-listed company (as part of a well balanced portfolio), and waiting until the fundamentals are build before the SP follows. That takes time, and for those wanting instant returns on their investment: sorry, you should have DYOR. This company here, all going well, has very good chances to succeed big time in the next 3 years, starting 2019. Since LK joined, he has build the foundations, but we need a couple floors before this turns into a skyscraper.
Note, that the company foresees to make a profit in Q1. the next level up from being cash flow positive.
Let’s see what they do with SWP and how they propose to fund that. The BOD has repeatedly said, there are other ways than placing to fund this. I would suggest to wait for the announcement from the BOD on that front; and not so much to listen to the self-proclaimed know-it-all on this BB. Sadly the pharmaceutical industry has not yet found a cure for hid mental illness, but I am told they are hopeful!!